Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;5(1-2):32-37.
doi: 10.1159/000486894. Epub 2018 Feb 16.

Intraplatelet Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor: New Biomarkers in Carcinoembryonic Antigen-Negative Colorectal Cancer?

Affiliations

Intraplatelet Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor: New Biomarkers in Carcinoembryonic Antigen-Negative Colorectal Cancer?

Charbel Chater et al. Gastrointest Tumors. 2018 Sep.

Abstract

Background/aim: Colorectal cancer (CRC) is associated with high incidence and mortality rates. Carcinoembryonic antigen (CEA), a prognostic biomarker for recurrent CRC following curative resection, suffers from low sensitivity, especially in early-stage screening. Intraplatelet angiogenesis regulators (IPAR), such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), have been identified as important regulators of tumor growth in CRC. The aim of this study was to confirm the higher preoperative level of IPAR (VEGF and PDGF) in CRC patients compared to controls and to measure IPAR in CEA-negative CRC patients.

Methods: The data and blood of 30 CRC patients and 30 presumably healthy controls were prospectively analyzed and compared.

Results: We confirmed elevated preoperative intraplatelet VEGF and PDGF levels in CRC patients compared to controls. Importantly, IPAR were significantly elevated even in CEA-negative CRC patients.

Conclusion: Elevated preoperative intraplatelet VEGF and PDGF levels in CRC patients suggest new possibilities for postoperative monitoring in CRC patients, especially when CEA is negative.

Keywords: Carcinoembryonic antigen; Colorectal cancer; Intraplatelet angiogenesis regulators; Platelet-derived growth factor; Vascular endothelial growth factor.

PubMed Disclaimer

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. - PubMed
    1. De Ridder JA, Lemmens VE, Overbeek LI, Nagtegaal ID, De Wilt., JH; Dutch Liver Surgery Group Liver resection for metastatic disease; a population-based analysis of trends. Dig Surg. 2016;33:104–113. - PubMed
    1. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51–64. - PubMed
    1. Maeda C, Hidaka E, Mori Y, Mukai S, Miyachi H, Sawada N, Ishida F, Kudo SE. Tumor diameter is an easy and useful predictor of recurrence in stage II colorectal cancer. Dig Surg. 2015;32:338–343. - PubMed
    1. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC., Jr ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24:5313–5327. - PubMed